Pant, 2008 - Google Patents
Lactobacillus based oro-mucosal therapies against rotavirusPant, 2008
View PDF- Document ID
- 8436121693491364225
- Author
- Pant N
- Publication year
- Publication venue
- PQDT-Global
External Links
Snippet
Rotavirus is the most important agent for severe infantile diarrhea, responsible for over 2 million diarrhea episodes and 600,000 deaths annually, mainly in the developing countries. Introduction of successful vaccine programs could help reduce the burden of rotavirus …
- 241000702670 Rotavirus 0 title abstract description 212
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/15—Reoviridae, e.g. calf diarrhea virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/542—Mucosal route oral/gastrointestinal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/42—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum viral
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Desselberger et al. | Immune responses to rotavirus infection and vaccination and associated correlates of protection | |
| Vega et al. | Recombinant monovalent llama-derived antibody fragments (VHH) to rotavirus VP6 protect neonatal gnotobiotic piglets against human rotavirus-induced diarrhea | |
| Pant et al. | Lactobacilli expressing variable domain of llama heavy-chain antibody fragments (lactobodies) confer protection against rotavirus-induced diarrhea | |
| Pant et al. | Effective prophylaxis against rotavirus diarrhea using a combination of Lactobacillus rhamnosus GG and antibodies | |
| LeCureux et al. | Lactobacillus mucosal vaccine vectors: immune responses against bacterial and viral antigens | |
| Corthésy et al. | Rotavirus anti-VP6 secretory immunoglobulin A contributes to protection via intracellular neutralization but not via immune exclusion | |
| Blutt et al. | The gastrointestinal frontier: IgA and viruses | |
| Al Kassaa | NEW INSIGHTS ON ANTIVIRAL PROBIOTICS. | |
| US8105592B2 (en) | Heavy chain and single domain antibodies | |
| Maffey et al. | Anti-VP6 VHH: an experimental treatment for rotavirus A-associated disease | |
| Coste et al. | Nasal immunization of mice with virus-like particles protects offspring against rotavirus diarrhea | |
| US20130164307A1 (en) | Use of camelid-derived variable heavy chain variable regions (vhh) targeting human cd18 and icam-1 as a microbicide to prevent hiv-1 transmission | |
| O’Ryan et al. | Vaccines for viral and bacterial pathogens causing acute gastroenteritis: Part I: Overview, vaccines for enteric viruses and Vibrio cholerae | |
| Al Kassaa | Antiviral probiotics: a new concept in medical sciences | |
| Li et al. | Oral vaccination with the porcine rotavirus VP4 outer capsid protein expressed by Lactococcus lactis induces specific antibody production | |
| Maffey et al. | Controlling Rotavirus-associated diarrhea: Could single-domain antibody fragments make the difference? | |
| KR20100040847A (en) | Hybrid operon for expression of colonization factor (cf) antigens of enterotoxigenic escherichia coli | |
| Xu et al. | Deciphering the potential of probiotics in vaccines | |
| CN100387300C (en) | Multivalent human-bovine rotavirus vaccine | |
| Pant | Lactobacillus based oro-mucosal therapies against rotavirus | |
| Desselberger | Rotaviruses: basic facts | |
| Marcotte et al. | Engineered lactobody-producing lactobacilli: a novel form of therapy against rotavirus infection | |
| Yuan et al. | Rotavirus | |
| De Greve et al. | Single domain antibodies from camelids in the treatment of microbial infections | |
| EA014328B1 (en) | Rotavirus vaccine inducing heterotypic cross protection |